Yeang C - Search Results

1

Imaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directions.

Briley-Saebo K, Yeang C, Witztum JL, Tsimikas S. Briley-Saebo K, et al. Among authors: yeang c. J Cardiovasc Transl Res. 2014 Nov;7(8):719-36. doi: 10.1007/s12265-014-9590-4. Epub 2014 Oct 9. J Cardiovasc Transl Res. 2014. PMID: 25297940 Free PMC article. Review.

2

Lipoprotein(a) is a Prevalent yet Vastly Underrecognized Risk Factor for Cardiovascular Disease.

Rendler J, Murphy M, Yeang C. Rendler J, et al. Among authors: yeang c. Health Care Curr Rev. 2024;12(2):397. Epub 2024 Mar 12. Health Care Curr Rev. 2024. PMID: 38525410 Free PMC article. No abstract available.

3

Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States.

Bhatia HS, Hurst S, Desai P, Zhu W, Yeang C. Bhatia HS, et al. Among authors: yeang c. J Am Heart Assoc. 2023 Sep 19;12(18):e031255. doi: 10.1161/JAHA.123.031255. Epub 2023 Sep 13. J Am Heart Assoc. 2023. PMID: 37702041 Free PMC article.

4

High lipoprotein(a): Actionable strategies for risk assessment and mitigation.

Reyes-Soffer G, Yeang C, Michos ED, Boatwright W, Ballantyne CM. Reyes-Soffer G, et al. Among authors: yeang c. Am J Prev Cardiol. 2024 Apr 3;18:100651. doi: 10.1016/j.ajpc.2024.100651. eCollection 2024 Jun. Am J Prev Cardiol. 2024. PMID: 38646021 Free PMC article. Review.

5

'LDL-C' = LDL-C + Lp(a)-C: implications of achieved ultra-low LDL-C levels in the proprotein convertase subtilisin/kexin type 9 era of potent LDL-C lowering.

Yeang C, Witztum JL, Tsimikas S. Yeang C, et al. Curr Opin Lipidol. 2015 Jun;26(3):169-78. doi: 10.1097/MOL.0000000000000171. Curr Opin Lipidol. 2015. PMID: 25943842 Review.

6

HDL-C, ABCA1-mediated cholesterol efflux, and lipoprotein(a): insights into a potential novel physiologic role of lipoprotein(a).

Yeang C, Tsimikas S. Yeang C, et al. J Lipid Res. 2015 Jul;56(7):1241-4. doi: 10.1194/jlr.E060947. Epub 2015 May 26. J Lipid Res. 2015. PMID: 26014961 Free PMC article. No abstract available.

7

Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis.

Capoulade R, Chan KL, Yeang C, Mathieu P, Bossé Y, Dumesnil JG, Tam JW, Teo KK, Mahmut A, Yang X, Witztum JL, Arsenault BJ, Després JP, Pibarot P, Tsimikas S. Capoulade R, et al. Among authors: yeang c. J Am Coll Cardiol. 2015 Sep 15;66(11):1236-1246. doi: 10.1016/j.jacc.2015.07.020. J Am Coll Cardiol. 2015. PMID: 26361154 Free article. Clinical Trial.

8

Experimental Animal Models Evaluating the Causal Role of Lipoprotein(a) in Atherosclerosis and Aortic Stenosis.

Yeang C, Cotter B, Tsimikas S. Yeang C, et al. Cardiovasc Drugs Ther. 2016 Feb;30(1):75-85. doi: 10.1007/s10557-015-6634-1. Cardiovasc Drugs Ther. 2016. PMID: 26780907 Review.

9

The role of lipoprotein(a) in progression of renal disease: Causality or reverse causality?

Yeang C, Tsimikas S. Yeang C, et al. J Diabetes Complications. 2016 Jul;30(5):755-7. doi: 10.1016/j.jdiacomp.2016.04.001. Epub 2016 Apr 7. J Diabetes Complications. 2016. PMID: 27118508 No abstract available.

10

PCSK9 Association With Lipoprotein(a).

Tavori H, Christian D, Minnier J, Plubell D, Shapiro MD, Yeang C, Giunzioni I, Croyal M, Duell PB, Lambert G, Tsimikas S, Fazio S. Tavori H, et al. Among authors: yeang c. Circ Res. 2016 Jun 24;119(1):29-35. doi: 10.1161/CIRCRESAHA.116.308811. Epub 2016 Apr 27. Circ Res. 2016. PMID: 27121620 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters